Cardiol Therapeutics Inc.
CRDL
$1.41
$0.032.17%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 3.26M | 4.12M | 7.62M | 3.68M | 3.77M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.87M | 7.14M | 10.37M | 5.66M | 6.23M |
Operating Income | -5.87M | -7.14M | -10.37M | -5.66M | -6.23M |
Income Before Tax | -5.77M | -5.84M | -9.33M | -4.82M | -6.81M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -5.77M | -5.84M | -9.33M | -4.82M | -6.81M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -5.77M | -5.84M | -9.33M | -4.82M | -6.81M |
EBIT | -5.87M | -7.14M | -10.37M | -5.66M | -6.23M |
EBITDA | -5.87M | -7.11M | -10.34M | -5.62M | -6.19M |
EPS Basic | -0.07 | -0.07 | -0.13 | -0.07 | -0.10 |
Normalized Basic EPS | -0.04 | -0.05 | -0.08 | -0.04 | -0.06 |
EPS Diluted | -0.07 | -0.07 | -0.13 | -0.07 | -0.10 |
Normalized Diluted EPS | -0.04 | -0.05 | -0.08 | -0.04 | -0.06 |
Average Basic Shares Outstanding | 82.61M | 80.41M | 69.84M | 68.75M | 67.26M |
Average Diluted Shares Outstanding | 82.61M | 80.41M | 69.84M | 68.75M | 67.26M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |